Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-641


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 429, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
TOB1 hsa-miR-641 low: 0 high: 1 1 2 2 0.704
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Helwak Aleksandra et al. 2013 IP Kidney FLPIN_TREX_293 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:50866159-50866201 CLASH POSITIVE DIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Helwak Aleksandra et al. 2013 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
MCL1 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:150574767-150574790 Chimeric fragments POSITIVE DIRECT TarBase 8.0
TUB hsa-miR-641 low: 0 high: 6 1 1 1 0.645
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr11:8105970-8105993 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr11:8105970-8105993 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:8105970-8105993 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr11:8105970-8105993 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr11:8105970-8105993 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:8105970-8105993 HITS-CLIP POSITIVE DIRECT TarBase 7.0
WEE1 hsa-miR-641 low: 0 high: 5 2 2 2 0.887
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:9588781-9588803 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr11:9589146-9589169 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr11:9589146-9589169 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr11:9589146-9589169 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:9589146-9589169 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BRD2 hsa-miR-641 low: 0 high: 5 1 1 1 -
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr6:32981250-32981272 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr6:32981250-32981272 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:32981250-32981272 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr6:32981250-32981272 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:32981250-32981272 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF367 hsa-miR-641 low: 0 high: 5 2 2 2 0.643
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr9:96386718-96386741 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr9:96386718-96386741 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr9:96386718-96386741 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr9:96386718-96386741 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr9:96386718-96386741 HITS-CLIP POSITIVE DIRECT TarBase 7.0
H1F0 hsa-miR-641 low: 0 high: 4 1 1 1 0.726
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr22:37807369-37807392 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr22:37807369-37807392 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr22:37807369-37807392 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr22:37807261-37807289 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ETF1 hsa-miR-641 low: 0 high: 3 2 2 2 0.816
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr5:138506718-138506740 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:138506718-138506740 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr5:138506718-138506740 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RNF11 hsa-miR-641 low: 0 high: 3 2 2 2 0.671
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:51272284-51272306 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:51271833-51271861 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:51271833-51271861 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EFCAB14 hsa-miR-641 low: 0 high: 3 1 1 1 0.962
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:46678049-46678068 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:46678049-46678068 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:46676523-46676547 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DYNLL2 hsa-miR-641 low: 0 high: 3 2 2 2 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr17:58089902-58089929 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:58089896-58089920 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr17:58095062-58095084 HITS-CLIP POSITIVE DIRECT TarBase 7.0
XRCC5 hsa-miR-641 low: 0 high: 3 1 1 1 0.483
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr2:216206189-216206213 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr2:216206189-216206213 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr2:216132343-216132369 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NUFIP2 hsa-miR-641 low: 0 high: 3 2 2 2 0.851
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr17:29263943-29263962 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29258869-29258883 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr17:29263943-29263962 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MIDN hsa-miR-641 low: 0 high: 3 1 1 1 0.515
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr19:1258836-1258863 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:1257370-1257398 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:1257370-1257398 HITS-CLIP POSITIVE DIRECT TarBase 7.0
UBE2W hsa-miR-641 low: 0 high: 3 1 1 1 0.793
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr8:73793536-73793556 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr8:73793536-73793556 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr8:73790351-73790377 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NUCKS1 hsa-miR-641 low: 0 high: 2 1 1 1 0.733
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:205714129-205714150 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:205714129-205714150 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SMARCA2 hsa-miR-641 low: 0 high: 2 2 2 2 0.950
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:2193500-2193526 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr9:2193500-2193526 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ICAM1 hsa-miR-641 low: 0 high: 2 2 2 2 0.498
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr19:10285763-10285787 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr19:10285811-10285831 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FNDC3A hsa-miR-641 low: 0 high: 2 1 2 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr13:49207857-49207878 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr13:49207857-49207878 PAR-CLIP POSITIVE DIRECT TarBase 7.0
HIPK3 hsa-miR-641 low: 0 high: 2 2 2 2 0.878
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr11:33353940-33353964 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr11:33287261-33287268 HITS-CLIP POSITIVE DIRECT TarBase 7.0